These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 10918575)

  • 1. Genetic dissection of c-myc apoptotic pathways.
    Nesbit CE; Tersak JM; Grove LE; Drzal A; Choi H; Prochownik EV
    Oncogene; 2000 Jun; 19(28):3200-12. PubMed ID: 10918575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways.
    Packham G; Cleveland JL
    Oncogene; 1997 Sep; 15(10):1219-32. PubMed ID: 9294616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The proto-oncogene c-myc and apoptosis.
    Hoffman B; Liebermann DA
    Oncogene; 1998 Dec; 17(25):3351-7. PubMed ID: 9916997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.
    Nilsson JA; Keller UB; Baudino TA; Yang C; Norton S; Old JA; Nilsson LM; Neale G; Kramer DL; Porter CW; Cleveland JL
    Cancer Cell; 2005 May; 7(5):433-44. PubMed ID: 15894264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways.
    Packham G; Porter CW; Cleveland JL
    Oncogene; 1996 Aug; 13(3):461-9. PubMed ID: 8760287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
    Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation.
    Amanullah A; Liebermann DA; Hoffman B
    Oncogene; 2002 Feb; 21(10):1600-10. PubMed ID: 11896589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N and C-terminal sub-regions in the c-Myc transactivation region and their joint role in creating versatility in folding and binding.
    Fladvad M; Zhou K; Moshref A; Pursglove S; Säfsten P; Sunnerhagen M
    J Mol Biol; 2005 Feb; 346(1):175-89. PubMed ID: 15663936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bax is a transcriptional target and mediator of c-myc-induced apoptosis.
    Mitchell KO; Ricci MS; Miyashita T; Dicker DT; Jin Z; Reed JC; El-Deiry WS
    Cancer Res; 2000 Nov; 60(22):6318-25. PubMed ID: 11103792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
    Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
    Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alpha1 subunit of GABAA receptor is repressed by c-myc and is pro-apoptotic.
    Vaknin UA; Hann SR
    J Cell Biochem; 2006 Apr; 97(5):1094-103. PubMed ID: 16294320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-modulation of c-myc expression by phorbol ester protects CEM T leukaemia cells from starvation-induced apoptosis: role of ornithine decarboxylase and polyamines.
    Tiberio L; Maier JA; Schiaffonati L
    Cell Death Differ; 2001 Oct; 8(10):967-76. PubMed ID: 11598794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of the N-terminal domain of the Myc oncoprotein.
    Oster SK; Mao DY; Kennedy J; Penn LZ
    Oncogene; 2003 Apr; 22(13):1998-2010. PubMed ID: 12673205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The proto-oncogene c-myc in hematopoietic development and leukemogenesis.
    Hoffman B; Amanullah A; Shafarenko M; Liebermann DA
    Oncogene; 2002 May; 21(21):3414-21. PubMed ID: 12032779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor and c-Myc transcription factors as putative partners in the in vivo cross-talk between androgen receptor-mediated and c-Met-mediated signalling pathways.
    Dudkowska M; Jaworski T; Grzelakowska-Sztabert B; Manteuffel-Cymborowska M
    Acta Biochim Pol; 2007; 54(2):253-9. PubMed ID: 17520086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-alpha enhances TNF-alpha-induced apoptosis through down-regulation of c-Myc protein expression in HL-60 cells.
    Nakashima A; Kumakura S; Mishima S; Ishikura H; Kobayashi S
    J Exp Clin Cancer Res; 2005 Sep; 24(3):447-56. PubMed ID: 16270532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myc potentiates apoptosis by stimulating Bax activity at the mitochondria.
    Soucie EL; Annis MG; Sedivy J; Filmus J; Leber B; Andrews DW; Penn LZ
    Mol Cell Biol; 2001 Jul; 21(14):4725-36. PubMed ID: 11416148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CCL6 chemokine is differentially regulated by c-Myc and L-Myc, and promotes tumorigenesis and metastasis.
    Yi F; Jaffe R; Prochownik EV
    Cancer Res; 2003 Jun; 63(11):2923-32. PubMed ID: 12782599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
    J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of reactive oxygen species, DNA damage, and c-Myc function by peroxiredoxin 1.
    Egler RA; Fernandes E; Rothermund K; Sereika S; de Souza-Pinto N; Jaruga P; Dizdaroglu M; Prochownik EV
    Oncogene; 2005 Dec; 24(54):8038-50. PubMed ID: 16170382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.